Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

中国专家对恶性胸膜间皮瘤诊断和治疗的共识

阅读：1
作者：Wang,Qian,Xu,Chunwei,Wang,Wenxian,Zhang,Yongchang,Li,Ziming,Song,Zhengbo,Wang,Jiandong,Yu,Jinpu,Liu,Jingjing,Zhang,Shirong,Cai,Xiuyu,Li,Wen,Zhan,Ping,Liu,Hongbing,Lv,Tangfeng,Miao,Liyun,Min,Lingfeng,Li,Jiancheng,Liu,Baogang,Yuan,Jingping,Jiang,Zhansheng,Lin,Gen,Chen,Xiaohui,Pu,Xingxiang,Rao,Chuangzhou,Lv,Dongqing,Yu,Zongyang,Li,Xiaoyan,Tang,Chuanhao,Zhou,Chengzhi,Zhang,Junping,Guo,Hui,Chu,Qian,Meng,Rui,Liu,Xuewen,Wu,Jingxun,Hu,Xiao,Zhou,Jin,Zhu,Zhengfei,Chen,Xiaofeng,Pan,Weiwei,Pang,Fei,Zhang,Wenpan,Jian,Qijie,Wang,Kai,Wang,Liping,Zhu,Youcai,Yang,Guocai,Lin,Xinqing,Cai,Jing,Feng,Huijing,Wang,Lin,Du,Yingying,Yao,Wang,Shi,Xuefei,Niu,Xiaomin,Yuan,Dongmei,Yao,Yanwen,Huang,Jianhui,Wang,Xiaomin,Zhang,Yinbin,Sun,Pingli,Wang,Hong,Ye,Mingxiang,Wang,Dong,Wang,Zhaofeng,Hao,Yue,Wang,Zhen,Wan,Bing,Lv,Donglai,Yu,Jianwei,Kang,Jin,Zhang,Jiatao,Zhang,Chao,Wu,Lixin,Shi,Lin,Ye,Leiguang,Wang,Gaoming,Wang,Yina,Gao,Feng,Huang,Jianfei,Wang,Guifang,Wei,Jianguo,Huang,Long,Li,Bihui,Zhang,Zhang,Li,Zhongwu,Liu,Yueping,Li,Yuan,Liu,Zhefeng,Yang,Nong,Wu,Lin,Wang,Qiming,Huang,Wenbin,Hong,Zhuan,Wang,Guansong,Qu,Fengli,Fang,Meiyu,Fang,Yong,Zhu,Xixu,Du,Kaiqi,Ji,Jiansong,Shen,Yi,Chen,Jing,Zhang,Yiping,Ma,Shenglin,Lu,Yuanzhi,Song,Yong,Liu,Anwen,Zhong,Wenzhao,Fang,Wenfeng
期刊：Thoracic Cancer影响因子：2.300
时间：2023起止号：2023 Sep;14(26):2715-2731
doi：10.1111/1759-7714.15022

Abstract

Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high-risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow-up.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。